Vimarsana
Biggest News Aggregation in the World

Page 7 - Unchained Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Unchained Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Unchained Labs Today - Breaking & Trending Today

Unchained Labs revs up its gene therapy engine, acquires NanoView Biosciences! - Vimarsana News

Unchained Labs revs up its gene therapy engine, acquires NanoView Biosciences!

PLEASANTON, Calif, May 4, 2022 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting biologics and gene therapy researchers the right tools for the job, acquired

Scilex Holding Company, a majority-owned subsidiary of - Vimarsana News

Scilex Holding Company, a majority-owned subsidiary of

PALO ALTO, Calif., April 12, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of...

Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members - Vimarsana News

Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members

17.03.2022 Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members | BB BIOTECH AG | News | Nachricht | Mitteilung

Source: dgap.de
Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members - Vimarsana News

Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members

17.03.2022 Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members | BB BIOTECH AG | News | Nachricht | Mitteilung

Source: dgap.de
Carlyle invests in medical device maker Resonetics, valuing company at $2.25bn - Vimarsana News

Carlyle invests in medical device maker Resonetics, valuing company at $2.25bn

Carlyle’s experience investing in medical products businesses includes Medline, Ortho Clinical Diagnostics, Unchained Labs, and MicroPort, among others.

Source: pehub.com